Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2018 February;59(1) > The Journal of Cardiovascular Surgery 2018 February;59(1):60-9

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEW  GLOBAL PERSPECTIVES ON DRUG ELUTING BALLOON TECHNOLOGY AND SCIENCE


The Journal of Cardiovascular Surgery 2018 February;59(1):60-9

DOI: 10.23736/S0021-9509.17.10214-4

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Drug coated balloons in the superficial femoral artery

Oliver SCHLAGER 1 , Michael E. GSCHWANDTNER 1, Andrea WILLFORT-EHRINGER 1, Florian WOLF 2, Christian LOEWE 2, Renate KOPPENSTEINER 1, Michael LICHTENBERG 3

1 Division of Angiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria; 2 Department of Cardiovascular and Interventional Radiology, Medical University of Vienna, Vienna, Austria; 3 Vascular Center Arnsberg Clinic, Arnsberg, Germany


PDF  


Despite the progress in endovascular treatment of patients with peripheral arterial disease, restenosis remains the major drawback, especially in patients with femoropopliteal lesions. To reduce neointimal proliferation and subsequent restenosis the use of antiproliferative drug eluting devices was implemented in the endovascular treatment of femoropopliteal disease. Aiming to use the favorable effects of these antiproliferative agents and to reduce foreign body exposure in affected arteries, drug coated balloons (DCB) have been developed. Up to now, several randomized controlled trials have consistently demonstrated the superiority of DCB over uncoated balloon angioplasty in the treatment of femoropopliteal lesions. Similarly, DCB appear to have favorable effects on vessel patency in the treatment of femoropopliteal in-stent restenosis. However, there still is a need for further studies, especially addressing different lesion characteristics as well as the combinations of particular treatment modalities.


KEY WORDS: Angioplasty, balloon - Femoral artery - Stents - Endovascular procedures

top of page

Publication History

Issue published online: November 28, 2017
Article first published online: September 20, 2017
Manuscript accepted: September 20, 2017
Manuscript received: September 8, 2017

Cite this article as

Schlager O, Gschwandtner ME, Willfort-Ehringer A, Wolf F, Loewe C, Koppensteiner R, et al. Drug coated balloons in the superficial femoral artery. J Cardiovasc Surg 2018;59:60-9. DOI: 10.23736/S0021-9509.17.10214-4

Corresponding author e-mail

oliver.schlager@meduniwien.ac.at